October 2023 – Page 4 – Goldea Capital

Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

Written by Customer Service on October 31, 2023. Posted in Earnings Releases And Operating Results.

New survival data from 15 patients in the Phase 2 ReSPECT-GBM trial of rhenium (186Re) obisbemeda in recurrent glioblastoma (rGBM) will be presented at SNO Annual Meeting on November 17th; Company will also host a Key Opinion Leader (KOL) event following the meeting to discuss the results Completed dosing in Cohort 4 of the Phase 1 ReSPECT-LM dose escalation trial with rhenium (186Re) obisbemeda for leptomeningeal metastases, the first of four additional planned cohorts in Part B (Cohorts 4-7); an update will also be provided at the SNO meeting in November Current cash of $11 million, plus an additional $10.2 million expected through the end of 2024 from the Cancer Prevention & Research Institute of Texas (CPRIT) grant, should provide sufficient runway to fund operations into 2025 Management to Host Conference Call Today at 5:00 p.m....

CymaBay Therapeutics to Report Third Quarter of 2023 Financial Results on Tuesday, November 7, 2023

Written by Customer Service on October 31, 2023. Posted in Earnings Releases And Operating Results.

NEWARK, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that it will host a conference call and live audio webcast on Tuesday, November 7, 2023 at 4:30 p.m. Eastern Time to discuss financial results for the third quarter ended September 30, 2023 and to provide a business update. Conference Call DetailsTo access the live conference call, please dial 1-877-407-0784 from the U.S. and Canada, or 1-201-689-8560 internationally, Conference ID #13740701. To access the live and subsequently archived webcast of the conference call, go to the Investors section of the company’s website at http://ir.cymabay.com/events. About CymaBay CymaBay Therapeutics, Inc. is a clinical-stage...

Key Tronic Corporation Announces Results for the First Quarter of Fiscal Year 2024

Written by Customer Service on October 31, 2023. Posted in Earnings Releases And Operating Results.

Year-over-Year Revenue Up 8%; New Program Wins SPOKANE VALLEY, Wash., Oct. 31, 2023 (GLOBE NEWSWIRE) — Key Tronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing services (EMS), today announced its results for the quarter ended September 30, 2023. These results are in line with the preliminary results announced on October 24, 2023. For the first quarter of fiscal year 2024, Keytronic reported total revenue of $147.8 million, up 8% from $137.3 million in the same period of fiscal year 2023. The Company’s gross margin for the first quarter of 2024 was 7.4% and operating margin was 2.2%, compared to a gross margin of 7.6% and an operating margin of 2.4% in the same period of fiscal 2023. For the first quarter of fiscal 2024, net income was $0.3 million or $0.03 per share, compared to $1.2 million or $0.11 per share...

Big 5 Sporting Goods Corporation Announces Fiscal 2023 Third Quarter Results

Written by Customer Service on October 31, 2023. Posted in Earnings Releases And Operating Results.

Declares Quarterly Cash Dividend of $0.125 Per Share EL SEGUNDO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) — Big 5 Sporting Goods Corporation (Nasdaq: BGFV) (the “Company,” “we,” “our,” “us,” “Big 5”), a leading sporting goods retailer, today reported financial results for the fiscal 2023 third quarter ended October 1, 2023. Steven G. Miller, the Company’s Chairman, President and Chief Executive Officer, said, “Our third quarter results came in slightly below our expectations, reflecting the increasing pressure over the course of the quarter on consumer discretionary spending resulting from a host of significant macroeconomic headwinds. In the face of the challenging sales environment, we have remained intently focused on optimizing merchandise margins, controlling expenses, and managing inventory, and we are pleased with our team’s...

MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023

Written by Customer Service on October 31, 2023. Posted in Public Companies.

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) will release its 2023 third quarter financial results and year to date financial results and its management will host a conference call to discuss these results and corporate updates at 5:00 PM (Eastern Time) on Tuesday, November 7, 2023. Presenting from the Company will be its Chief Executive Officer, Michael Castagna, and Chief Financial Officer, Steven Binder. Those interested in listening to the conference call live via the Internet may do so by visiting the Company’s website at https://investors.mannkindcorp.com/events-and-presentations under Events & Presentations. About MannKind CorporationMannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic...

OmniLit Acquisition Corp. Shareholders Approve Syntec Optics Merger

Written by Customer Service on October 31, 2023. Posted in Mergers And Acquisitions.

MIAMI BEACH, FLORIDA, Oct. 31, 2023 (GLOBE NEWSWIRE) — OmniLit Acquisition Corp. (“OLIT”) (Nasdaq: OLIT), a publicly traded special purpose acquisition company, today announced that its shareholders voted to approve the previously announced business combination with Syntec Optics, Inc. (“Syntec Optics”) at OLIT’s Annual meeting of shareholders held today, October 31, 2023 (the “Annual Meeting”). Over 99.9% of the votes cast at the Annual Meeting for the Business Combination Proposal were cast in favor. OLIT shareholders also voted to approve all other proposals presented at the Annual Meeting. OLIT plans to file the results of the Annual Meeting, as tabulated by the inspector of election, with the Securities and Exchange Commission (the “SEC”) on a Form 8-K. About Syntec Optics Syntec Optics, headquartered in Rochester, NY, is...

Nokia Corporation: Repurchase of own shares on 31.10.2023

Written by Customer Service on October 31, 2023. Posted in Public Companies.

STOCK EXCHANGE RELEASE 31 October 2023 Nokia CorporationStock Exchange Release 31 October 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 31.10.2023 Espoo, Finland – On 31 Oct 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* AQEU 16,873 3.13 CEUX 48,678 3.13 TQEX 14,635 3.12 XHEL 369,814 3.13 Total 450,000 3.13 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is...

Groupe Casino: Details of the backstopped capital increase of 275 million euros to be implemented as part of the financial restructuring

Written by Customer Service on October 31, 2023. Posted in Public Companies.

Details of the backstopped capital increases of 275 million euros to be implemented as part of the financial restructuring Paris, 31 October 2023 Further to its press release of 5 October 2023, Casino Group announces that on 25 October 2023 at midnight (CET), the last commitment date for subscribing to the €275 million backstopped capital increases, Casino has received commitments to subscribe from the creditors for a total amount of approximately €195 million (i.e. circa 71% of the amount to be subscribed). In accordance with the lock-up agreement dated 5 October 20231, the Group, the Consortium and the initial secured creditors who undertook to backstop the capital increase have decided, in view on the one hand of the subscription undertakings received, the additional time and costs incurred by a rights issue, and on the other hand of...

Publishing of Eimskip’s third quarter 2023 results

Written by Customer Service on October 31, 2023. Posted in Earnings Releases And Operating Results.

Investor meeting on 8 November 2023 Eimskipafélag Íslands hf. will publish its third quarter 2023 results after market closing on Tuesday 7 November. Eimskip invites investors and market participants to a meeting where Vilhelm Thorsteinsson, CEO and María Björk Einarsdóttir, CFO, will present the results. The meeting will be held on Wednesday 8 November at 8:30 GMT at the Company‘s headquarters, Sundabakki 2, second floor. The meeting will also be webcasted live in Icelandic on www.eimskip.com/investors. Investors can send questions before and during the meeting to the email investors@eimskip.com. Documents and a recording of the meeting will be available at the Company’s investor relations website, www.eimskip.is/investors. For further information please contact Guðbjörg Birna Björnsdóttir, Head of Treasury and Investor Relations, tel:...

CORRECTION – Greif Plans to Acquire IPACKCHEM

Written by Customer Service on October 31, 2023. Posted in Mergers And Acquisitions.

DELAWARE, Ohio, Oct. 31, 2023 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Greif, Inc. (NYSE: GEF, GEF.B), please note that, in footnote (1), “within 48 months of planned ownership” should read “within 18 months of planned ownership.” The corrected release follows: Highlights IPACKCHEM is a global leader in premium barrier and non-barrier jerrycans and small plastic containers Platform investment supports future growth in EMEA and APAC, with unique barrier technology, best-in-class facilities across five continents, and strong technical and operational management Favorable exposure to secular growth markets in agriculture, specialty chemicals, flavor & fragrances, and pharmaceutical & medical diagnostics Financial profile is immediately accretive to EBITDA margins...

Month: October 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice